
Sign up to save your podcasts
Or


Ari Paparo and Eric Franchi speak with Josh Walsh, founder and CEO of BranchLab, about how pharmaceutical advertising is changing. The discussion covers BranchLab’s use of neural networks with non-health data, the impact of new privacy regulations, and recent funding from Lance Armstrong’s Next Ventures. The conversation also touches on Deep Intent’s acquisition, ongoing federal policy debates, and the broader implications for healthcare marketing.
Takeaways
Chapters
00:00 – Introductions
02:00 – What BranchLab Does
05:00 – Funding from Next Ventures
07:30 – Industry Context
09:30 – Data and Privacy
13:00 – Federal Policy
16:30 – The Road Ahead
20:00 – Wrap-Up
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Ari Paparo5
2020 ratings
Ari Paparo and Eric Franchi speak with Josh Walsh, founder and CEO of BranchLab, about how pharmaceutical advertising is changing. The discussion covers BranchLab’s use of neural networks with non-health data, the impact of new privacy regulations, and recent funding from Lance Armstrong’s Next Ventures. The conversation also touches on Deep Intent’s acquisition, ongoing federal policy debates, and the broader implications for healthcare marketing.
Takeaways
Chapters
00:00 – Introductions
02:00 – What BranchLab Does
05:00 – Funding from Next Ventures
07:30 – Industry Context
09:30 – Data and Privacy
13:00 – Federal Policy
16:30 – The Road Ahead
20:00 – Wrap-Up
Learn more about your ad choices. Visit megaphone.fm/adchoices

1,294 Listeners

532 Listeners

172 Listeners

9,502 Listeners

1,087 Listeners

557 Listeners

72 Listeners

43 Listeners

5,486 Listeners

261 Listeners

89 Listeners

504 Listeners

32 Listeners

10 Listeners

0 Listeners